LLMpediaThe first transparent, open encyclopedia generated by LLMs

Cinchona ledgeriana

Generated by DeepSeek V3.2
Note: This article was automatically generated by a large language model (LLM) from purely parametric knowledge (no retrieval). It may contain inaccuracies or hallucinations. This encyclopedia is part of a research project currently under review.
Article Genealogy
Parent: Cinchona Hop 4
Expansion Funnel Raw 57 → Dedup 0 → NER 0 → Enqueued 0
1. Extracted57
2. After dedup0 (None)
3. After NER0 ()
4. Enqueued0 ()
Cinchona ledgeriana
NameCinchona ledgeriana
GenusCinchona
Speciesledgeriana
Authority(Howard) Bern.Moens ex Trimen

Cinchona ledgeriana. It is a species of flowering plant within the Rubiaceae family, renowned for its exceptionally high content of the antimalarial alkaloid quinine. Native to the eastern slopes of the Andes in South America, particularly within regions of Bolivia and Peru, it became the cornerstone of the global quinine industry in the 19th and 20th centuries. The plant's history is deeply intertwined with colonialism, medicine, and economic botany, shaping events from the treatment of malaria in British India to the exploitation of resources during the Dutch colonial enterprise in the Dutch East Indies.

Description and taxonomy

The species is classified within the genus Cinchona, which was named by Carl Linnaeus in the 18th century, allegedly after the Countess of Chinchón. It is a small to medium-sized evergreen tree, typically growing in the cloud forests of the Andes. Botanically, it is distinguished by its lance-shaped leaves, terminal panicles of fragrant, pink or white flowers, and its small, capsular fruit. The taxonomy of the genus has been historically complex, with significant work by botanists like John Eliot Howard and George Bentham helping to clarify species distinctions. The specific epithet "ledgeriana" honors the English trader Charles Ledger, who facilitated the acquisition of its seeds.

Historical significance

The historical impact of this species is profound, beginning with the traditional use of cinchona bark by indigenous peoples in the Viceroyalty of Peru. Its value was recognized by Jesuit missionaries, who introduced "Jesuit's bark" to Europe in the 17th century. The pivotal moment came in the 1860s, when Charles Ledger and his servant Manuel Incra Mamani procured seeds of the high-yielding variety. These seeds were subsequently obtained by the British and, more successfully, by the Dutch, who established massive plantations in Java under the direction of the Dutch East India Company's successors. This broke the Spanish and later Bolivian monopoly on bark, transforming the Dutch East Indies into the world's primary quinine source and influencing colonial health policies across Africa and Asia.

Cultivation and production

Successful large-scale cultivation was pioneered in the Dutch East Indies, particularly on the islands of Java and, later, Sumatra. The Hortus Botanicus Amsterdam played a key role in propagating the initial seeds. Cultivation techniques were refined by Dutch planters and scientists, leading to the development of high-yield estates that supplied the Dutch government and companies like the Amsterdam Quinine Company. The industry faced a major crisis during the Japanese occupation of the Dutch East Indies in World War II, which cut off Allied supplies and spurred the development of synthetic antimalarials like chloroquine. Post-war production continued but at a reduced scale due to competition from synthetics and political changes following the Indonesian National Revolution.

Medicinal uses and alkaloids

The bark is the source of several medicinally important alkaloids, most notably quinine and quinidine. Quinine was the first effective treatment for malaria, a disease that plagued expeditions, colonial armies, and indigenous populations, and was crucial for European activities in regions like British India and French Indochina. The British Army and the United States Armed Forces relied on it extensively. Quinidine became an important antiarrhythmic agent for treating heart conditions. The isolation of quinine is credited to French chemists Pierre Joseph Pelletier and Joseph Bienaimé Caventou in 1820. Its use declined after the development of chloroquine by Bayer and others, but it has seen resurgence in treating multidrug-resistant malaria.

Conservation status and threats

In its native Andes habitat, wild populations have suffered from historical over-exploitation during the "Cinchona bark" boom and ongoing deforestation. The species is not currently listed on the IUCN Red List for most specific assessments, but the genus faces general threats. Conservation efforts are linked to broader initiatives to protect biodiversity hotspots in the Tropical Andes. Ex situ collections are maintained in botanical gardens such as the Royal Botanic Gardens, Kew and the Hortus Botanicus Leiden, which preserve genetic material. The primary threats remain habitat loss due to agriculture and a reduced economic incentive for its cultivation compared to historical peaks.

Category:Rubiaceae Category:Medicinal plants Category:Flora of South America